CC25 Content

Lecturer: Selwyn M. Vickers, MD, FACS; President & CEO, Memorial Sloan Kettering Cancer Center, New York, NY

Announcing the Commission on Cancer Oncology Lecturer

Dr. Selwyn M. Vickers to Deliver a Lecture Titled: The Promising Future of Cancer Therapeutics and Care

NL07 - Tuesday, October 7, 2025 | 12:45–1:45 pm CT

Selwyn M. Vickers, MD, FACS is president and CEO of Memorial Sloan Kettering Cancer Center (MSK) and director of the MSK Comprehensive Cancer Center. He is a world-renowned surgeon, pancreatic cancer researcher, and pioneer in health disparities research. His major research interests include gene therapy as an application in the treatment of pancreatobiliary tumors, the role of growth factors and receptors in the oncogenesis of pancreatic cancer, the implications of FAS expressions and Tamoxifen in the growth and treatment of cholangiocarcinoma, assessment of clinical outcomes in the surgical treatment of pancreatobiliary tumors, and the role of death receptors in the treatment of pancreatic cancer.

Vickers is a member of the National Academy of Medicine (NAM), fellow of the American Association for Cancer Research and honorary member of the American Society for Clinical Investigation. He is a member of over 22 professional societies and has held leadership roles in many including the NAM, American Surgical Association and Society of Black Academic Surgeons. He has more than 270 peer-reviewed publications spanning 25 years of NIH funding investigating the molecular basis for pancreatic adenocarcinoma, developing novel therapeutic approaches, and understanding disparities in cancer incidence, access to care, and clinical trial enrollment.

Vickers has held several academic leadership roles including chair of the department of surgery at the University of Minnesota Medical School, dean and senior vice president of the Heersink School of Medicine at University of Alabama at Birmingham (UAB) and CEO of the UAB Health Systems and CEO of the UAB/Ascension St. Vincent’s Alliance.

Cancer Programs Panel Sessions at Clinical Congress 2025

Topic	Date	Time	Room
PS302 Hot Topics in Surgical Oncology	10/7/2025	8:00–9:30 am	TBD
PS206 Management of Gastrointestinal Oncologic Surgical Emergencies	10/6/2025	8:00–9:30 am	TBD
PS314 Updates in Colorectal Cancer Liver Metastases	10/7/2025	9:45–11:15 am	TBD
PS112 Molecular Testing and Targeted Therapy for Pancreatic Cancer	10/5/2025	11:30 am–1:00 pm	TBD
PS128 Genetic Testing for Newly Diagnosed Breast Cancer Patients	10/5/2025	4:15–5:45 pm	TBD
PS313 Management of Clinically High-Risk HR Positive, Her2-Neu Negative Breast Cancer	10/7/2025	9:45–11:15 am	TBD
PS325 Considerations for Neoadjuvant Chemotherapy vs Upfront Surgery in Early-Stage Breast Cancer	10/7/2025	2:30–4:00 pm	TBD
PS119 Breast Cancer Screening: Current State and Future Directions	10/5/2025	2:30–4:00 pm	TBD
PS230 The Evolving Treatment of Rectal Cancer: A Closer Look	10/6/2025	2:30–4:00 pm	TBD
CoC Meetings at Congress	8:00–10:00 am CoC Executive Committee Meeting (by invitation only – Executive Committee Members) 10:15 am–12:00 pm CoC State Chair Town Hall (by invitation only – State Chairs and Executive Committee Members) 12:15–1:15 pm CoC Luncheon (open to all CoC members and State Chairs) 1:30–5:00 pm CoC Plenary Session (open to all)

All meetings will be held at:

Hyatt Regency McCormick Place
2233 S. Martin Luther King Dr.
Chicago, IL 60616
(312) 597-1234

Cancer Programs Events at Clinical Congress 2025

Announcing the Commission on Cancer Oncology Lecturer

Dr. Selwyn M. Vickers to Deliver a Lecture Titled: The Promising Future of Cancer Therapeutics and Care

Cancer Programs Panel Sessions at Clinical Congress 2025

Topic

Date

Time

Room